BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 18298593)

  • 1. Release of immune modulation factors from platelet concentrates during storage after photochemical pathogen inactivation treatment.
    Cognasse F; Osselaer JC; Payrat JM; Chavarin P; Corash L; Garraud O
    Transfusion; 2008 May; 48(5):809-13. PubMed ID: 18298593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of potential immunomodulatory factors during platelet storage.
    Cognasse F; Boussoulade F; Chavarin P; Acquart S; Fabrigli P; Lamy B; Garraud O
    Transfusion; 2006 Jul; 46(7):1184-9. PubMed ID: 16836566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine accumulation in photochemically treated and gamma-irradiated platelet concentrates during storage.
    Apelseth TO; Hervig TA; Wentzel-Larsen T; Bruserud O
    Transfusion; 2006 May; 46(5):800-10. PubMed ID: 16686848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage.
    Apelseth TØ; Bruserud Ø; Wentzel-Larsen T; Bakken AM; Bjørsvik S; Hervig T
    Transfusion; 2007 Apr; 47(4):653-65. PubMed ID: 17381624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light.
    Wagner SJ; Skripchenko A; Myrup A; Awatefe H; Thompson-Montgomery D; Moroff G; Carmichael P; Lin L
    Transfusion; 2009 Apr; 49(4):704-10. PubMed ID: 19171001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
    Skripchenko A; Kurtz J; Moroff G; Wagner SJ
    Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system.
    Vetlesen A; Mirlashari MR; Ezligini F; Kjeldsen-Kragh J
    Transfusion; 2007 Jan; 47(1):126-32. PubMed ID: 17207241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukoreduced buffy coat-derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7 days: assessment of hemostatic function under flow conditions.
    Lozano M; Galan A; Mazzara R; Corash L; Escolar G
    Transfusion; 2007 Apr; 47(4):666-71. PubMed ID: 17381625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
    Shanwell A; Diedrich B; Falker C; Jansson B; Sandgren P; Sundkvist L; Svensson L; Vesterinen M; Gulliksson H
    Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.
    Janetzko K; Lin L; Eichler H; Mayaudon V; Flament J; Klüter H
    Vox Sang; 2004 May; 86(4):239-45. PubMed ID: 15144528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: process used in the SPRINT trial.
    Pineda A; McCullough J; Benjamin RJ; Cable R; Strauss RG; Burgstaler E; Porter S; Lin L; Metzel P; Conlan MG;
    Transfusion; 2006 Apr; 46(4):562-71. PubMed ID: 16584432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
    Moog R; Fröhlich A; Mayaudon V; Lin L
    J Clin Apher; 2004; 19(4):185-91. PubMed ID: 15597347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of bacterial inactivation in prestorage pooled, leukoreduced, whole blood-derived platelet concentrates suspended in plasma prepared with photochemical treatment.
    Brecher ME; Hay S; Corash L; Hsu J; Lin L
    Transfusion; 2007 Oct; 47(10):1896-901. PubMed ID: 17880617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal by adsorbent beads of biological response modifiers released from platelets, accumulated during storage, and potentially associated with platelet transfusion reactions.
    Tanaka S; Hayashi T; Tani Y; Hirayama F
    Transfusion; 2010 May; 50(5):1096-105. PubMed ID: 20051054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of simulated shipping conditions (24- or 30-hr interruption of agitation) on the in vitro properties of apheresis platelets during 7-day storage.
    Wagner SJ; Vassallo R; Skripchenko A; Einarson M; Seetharaman S; Moroff G
    Transfusion; 2008 Jun; 48(6):1072-80. PubMed ID: 18373503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Level of platelet-derived cytokines in leukoreduced red blood cells is influenced by the processing method and type of leukoreduction filter.
    Glenister KM; Sparrow RL
    Transfusion; 2010 Jan; 50(1):185-9. PubMed ID: 19694993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates.
    Ambruso DR; Thurman G; Marschner S; Goodrich RP
    Transfusion; 2009 Dec; 49(12):2631-6. PubMed ID: 19694996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance of platelet in vitro properties during 7-day storage in M-sol with a 30-hour interruption of agitation.
    Wagner SJ; Myrup A; Awatefe H; Thompson-Montgomery D; Hirayama J; Skripchenko A
    Transfusion; 2008 Dec; 48(12):2501-607. PubMed ID: 18764828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet function assessed by shear-induced deposition of split triple-dose apheresis concentrates treated with pathogen reduction technologies.
    Picker SM; Schneider V; Gathof BS
    Transfusion; 2009 Jun; 49(6):1224-32. PubMed ID: 19220821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma.
    Zhang JG; Carter CJ; Culibrk B; Devine DV; Levin E; Scammell K; Weiss S; Gyongyossy-Issa MI
    Transfusion; 2008 May; 48(5):847-56. PubMed ID: 18298601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.